首页> 外文期刊>Nature >Ultra-large library docking for discovering new chemotypes
【24h】

Ultra-large library docking for discovering new chemotypes

机译:超大型图书馆对接系统,可发现新的化学类型

获取原文
获取原文并翻译 | 示例
           

摘要

Despite intense interest in expanding chemical space, libraries containing hundreds-of-millions to billions of diverse molecules have remained inaccessible. Here we investigate structure-based docking of 170 million make-on-demand compounds from 130 well-characterized reactions. The resulting library is diverse, representing over 10.7 million scaffolds that are otherwise unavailable. For each compound in the library, docking against AmpC beta-lactamase (AmpC) and the D-4 dopamine receptor were simulated. From the top-ranking molecules, 44 and 549 compounds were synthesized and tested for interactions with AmpC and the D-4 dopamine receptor, respectively. We found a phenolate inhibitor of AmpC, which revealed a group of inhibitors without known precedent. This molecule was optimized to 77 nM, which places it among the most potent non-covalent AmpC inhibitors known. Crystal structures of this and other AmpC inhibitors confirmed the docking predictions. Against the D-4 dopamine receptor, hit rates fell almost monotonically with docking score, and a hit-rate versus score curve predicted that the library contained 453,000 ligands for the D-4 dopamine receptor. Of 81 new chemotypes discovered, 30 showed submicromolar activity, including a 180-pM subtype-selective agonist of the D-4 dopamine receptor.
机译:尽管人们对扩大化学空间有着浓厚的兴趣,但仍无法访问包含数亿至数十亿个不同分子的文库。在这里,我们研究了来自130个特征明确的反应的1.7亿个按需制造化合物的基于结构的对接。生成的库是多样化的,代表了超过1070万个否则无法使用的支架。对于文库中的每种化合物,模拟了针对AmpCβ-内酰胺酶(AmpC)和D-4多巴胺受体的对接。从排名靠前的分子合成了44和549种化合物,并分别测试了它们与AmpC和D-4多巴胺受体的相互作用。我们发现了AmpC的酚盐抑制剂,揭示了一组尚无先例的抑制剂。该分子被优化为77 nM,使其成为已知的最有效的非共价AmpC抑制剂。这种和其他AmpC抑制剂的晶体结构证实了对接预测。针对D-4多巴胺受体,命中率几乎与对接得分单调下降,命中率与得分的关系曲线预测该文库包含453,000个D-4多巴胺受体配体。在发现的81种新化学型中,有30种表现出亚微摩尔活性,包括D-4多巴胺受体的180 pM亚型选择性激动剂。

著录项

  • 来源
    《Nature》 |2019年第7743期|224-229|共6页
  • 作者单位

    Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94115 USA;

    Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA;

    Enamine, Kiev, Ukraine;

    East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai, Peoples R China;

    Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA;

    Univ N Carolina, Sch Med, NIMH PDSP, Chapel Hill, NC 27515 USA;

    Chemspace, Riga, Latvia;

    Natl Taras Shevchenko Univ Kiev, Kiev, Ukraine;

    Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, Shanghai, Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号